Jeffrey Kornitzer
Neurology with Special Qualifications in Child Neurology · Newark, NJNPI 1932499266
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $500 and has fallen 57.4% since, to $213 in 2025.
Across 88 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$188
- Corium, LLC$159
- UCB, Inc.$147
- Neurelis, Inc.$111
- Supernus Pharmaceuticals, Inc.$107
- Biomarin Pharmaceutical Inc.$88
- plus $944 from 32 others
What the payments were for
- Food & beverage$1,745100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 3 | $188 |
| Corium, LLC | 12 | $159 |
| UCB, Inc. | 8 | $147 |
| Neurelis, Inc. | 7 | $111 |
| Supernus Pharmaceuticals, Inc. | 7 | $107 |
| Biomarin Pharmaceutical Inc. | 3 | $88 |
| Eisai Inc. | 4 | $87 |
| Jazz Pharmaceuticals Inc. | 4 | $70 |
| AstraZeneca | 3 | $51 |
| Chiesi USA, Inc. | 1 | $47 |
| NS Pharma, Inc. | 2 | $46 |
| Tris Pharma Inc | 3 | $45 |
| Johnson & Johnson | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| KARL Storz Endoscopy-america | 1 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Aquestive Therapeutics, Inc. | 2 | $32 |
| Neos Therapeutics, LP | 2 | $29 |
| Immedica Pharma US, Inc. | 2 | $28 |
| Integra Lifesciences Corporation | 1 | $27 |
| Medtronic | 1 | $25 |
| Mimedx Group, Inc. | 1 | $24 |
| Intrabio Inc | 1 | $23 |
| SK Life Science, Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| ITF Therapeutics LLC | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $17 |
| Avion Pharmaceuticals | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Aprecia Pharmaceuticals, LLC | 1 | $15 |
| Metacel Pharmaceuticals LLC | 1 | $15 |
| Novartis | 1 | $15 |
| Greenwich Biosciences, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| PTC Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Sentiva$146
How this compares
$1,745 in reported general payments places this provider in the 75th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Other neurology with special qualifications in child neurology in Newark
- Anjum HashimNewark$696
- Misbah SalamNewark$530
- Lisa FordNewark$295
- Caroline Hayes-RosenNewark$102
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Sara RubensteinHackensack$7K
- Carlos LastraNew Brunswick$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.